Introduction GDM is a leading metabolic cause of morbidity to mother and offspring. Determining its prevalence is important for health planning and implementation.
Introduction
Gestational diabetes mellitus (GDM) is a common metabolic disorder of pregnancy and it is the leading cause of short and long term morbidity to mother and offspring. It is associated with a significantly increased risk of fetal macrosomia, shoulder dystocia, birth injuries as well as neonatal hypoglycemia and hyperbilirubinemia [1] . Even borderline GDM has been linked with an increased frequency of perinatal complications, with the maternal glycaemia demonstrating a continuum effect on perinatal outcome [2] . In GDM, concurrent pregnancy-induced hypertension further increases the adverse outcomes [1] . Babies born to mothers with GDM are at increased risk of developing obesity, diabetes and metabolic syndrome in childhood and early adulthood [1] . Further, studies have demonstrated an increased risk of future GDM in girls born to mothers with GDM affecting their index pregnancies [3] . Pregnancies complicated by GDM have higher rates of caesarean sections and induced deliveries, with approximately 10-30% developing pre-eclampsia [1] . Women with GDM have a high risk of developing type 2 diabetes (DM) within five years postpartum with a doubling of the risk after the first five years [4] . In South India, the reported incidence of postpartum DM among women with history of previous GDM is even higher within the first five years with over 90% being affected within 10 years of delivery [5] . After delivery, women with GDM often have an increased risk of developing metabolic syndrome, which is also seen in South Asian women [1, [6] [7] [8] .
The prevalence of GDM varies across the world, with differing diagnostic criteria causing difficulty in comparing prevalence rates between geographical regions and ethnic groups. However, an increasing prevalence is noted throughout the world [9] [10] [11] . A high prevalence of GDM is reported in India, with urban (17.8%), semi urban (13.8%) and rural (9.9%) variations based on WHO 1999 criteria [12] . The Sri Lankan data mirrors this with an approximate doubling of prevalence over seven years Paper from 5.5% in 1998 to 10.3% in 2004 [13, 14] . [15] . The study population consisted of women confirmed biochemically as pregnant with a period of amenorrhoea (POA) less than 12 weeks at the time of registration by the Public Health Midwife (PHM). Those diagnosed as having DM before pregnancy, prescribed diabetogenic drugs such as steroids, anti-epileptics and anti-psychotics, having severe co-morbidities or mental subnormality were excluded from the study at recruitment. The required sample size was 1324 with 1.96 of standard normal deviation for 5% a error, 0.025 precision and 2.8 design effect. Most recent community prevalence of GDM in Sri Lanka (8.4%) was used for calculating the sample size [14] . A further 10% was added to compensate for non-responders and another 10% allowance made for miscarriages. The final calculated sample size was 1600.
The sample was selected in three stages; firstly, two MOH areas were randomly selected from the 16 areas. Secondly, within the selected MOH areas, all the PHM areas (n=88) with cumulative population were listed. The cluster size was considered as 20. This number was determined based on feasibility of recruiting the required total sample within the first 3 months of the study and local logistics. Thirdly, after selection of the first cluster randomly, 80 clusters were selected according to probability proportionate to size of the PHM areas. Finally, from the selected PHM areas,the Pregnancy Register was used to select pregnant women less than a POA of 12 weeks. First eligible name was selected randomly. Thereafter; every consecutive name until achieving the required number was recruited, adhering to the inclusion and exclusion criteria.
All registered pregnant women were requested to attend the identified field clinics. A survey carried out to assess the completeness of registration of pregnant women by the principal investigator revealed that pregnant women registration rate was over 98% in these two MOH areas.
Data were gathered from all consenting pregnant women using an interviewer administered structured questionnaire. The 2 hour post prandial plasma glucose (2 hr PPBS) test following a standard Sri Lankan meal and fasting 75 g oral glucose tolerance test (75 g OGTT) were chosen as the first trimester screening and diagnostic method respectively [16] [17] [18] [19] . The 2 hr PPBS cut off value of 120 mg/dl was determined as a proxy measure to detect probable previously unknown diabetic women, since this is the internationally recognised glycaemic target recommended for managing diabetes during pregnancy [20] . We selected women based on 2 hr PPBS value exceeding 120 mg/dl as probable diabetes complicating pregnancy to be confirmed by the gold standard fasting 75 g OGTT performed in early pregnancy (before the prescribed timing of 24 weeks). GDM was diagnosed by WHO 1999 criteria (fasting plasma glucose value≥ 126 mg/dl or 2 hour plasma glucose value of ≥ 140mg/dl) in 75 g OGTT to enable comparison with previous prevalence rates using the identical criteria [19] .
All consenting participants were universally screened for GDM. Firstly, they underwent the 2 hr PPBS test in the first trimester; where those with a value above 200 mg were identified as having GDM (by WHO 1999 criteria) and most probably diabetes in pregnancy (DIP) and referred appropriately [21] . Those who had 2 hr PPBS above 120 mg/dl but less than 200 mg underwent fasting 75 g OGTT before 16 weeks of POA [16, 17] . All mothers who had 2 hr PPBS values <120 mg/dl in 1 st trimester and those with >120mg/dl and < 200mg/dl but with normal OGTT at 16 weeks underwent mandatory fasting 75 g OGTT between 24-28 weeks if they remained pregnant [19, 22] . Those who were negative for GDM at 24-28 weeks underwent OGTT at 32-36 weeks. The 2 hr PPBS and fasting 75 g OGTT testing were performed with venous plasma in an accredited laboratory.
Approval for the study was granted by the Ethics Review Committee (ERC) of the Medical Research Institute, Colombo. Written informed consent was obtained from all patients.
Results
The total number of pregnant women recruited for the study was 1600. Non response rate was 4.2% (n=67) and 1533 underwent 2 hr PPBS in first trimester (response rate 95.8%). Forty had 2 hr PPBS value > 120 mg/dl, of them four had more than 200 mg/dl and were diagnosed as GDM/probable DIP. The remaining 36 (PPBS ≥ 120 mg/dl ≤ 200 mg) underwent OGTT before 16 weeks of POA. Of them 15 had GDM. Ninteen pregnant women developed GDM before 16 weeks of POA (1.2%). One hundred and thirty four (8.4%) had mis-carriages and were excluded from the study except one who had an early abnormal OGTT prior to pregnancy loss. The total population eligible for OGTT between 24-28 weeks was 1381, of them 150 had GDM (10.9%). A total of 169 pregnant women in the study sample developed GDM before 28 The final sample consisted of 1400 participants, whose characteristics are shown in Table 1 .
Among those with GDM (n=194); mean age was 31.74 ± 5.11years, 64 (33%) were primigravid and 75 (38.7%) were in their second, 38 (19.6%) third, 11 (5.7%) fourth and fifth 5 (2.6%) pregnancies. Mean body mass index (BMI) was 24.20 ± 4.58 but 8.5% were underweight. Sixty seven (34.5%) with GDM had maternal history of diabetes and 42 (21.6%) had paternal diabetes history. Overall, 91 (46.9%) participants with GDM had parental history of diabetes (one or both parent). Ten had past history of GDM; five in the first, three in second and one each in third and fourth pregnancies.
Univariate analysis revealed the following asso- 
Discussion
The current prevalence of GDM in the District of Gampaha, Sri Lanka is high. Age more than 35 years, maternal overweight/obesity, parental diabetes and previous GDM were significantly associated with the GDM after adjusting for the confounding effect.
The current study confirms that rate of GDM has increased in Sri Lanka. In 1998, 5.5% of a cohort of 721 Paper pregnant women attending antenatal clinics at Sri Jayawardenepura General Hospital were identified as affected using the 75 g OGTT and WHO criteria [13] . A community based study conducted in 2004 of 853 pregnant women in Homagama MOH area reported a rate of 8.4% (75 g OGTT and 1999 WHO criteria) with the rate increasing with maternal age (<25 years 3%, 25-35 years 9.6% and ³ 35 years 15.9%) and the age standardised prevalence was10.3% [14] . The current study shows a prevalence of 13.9% in a more rural setting that confirms the increasing trend of gestational diabetes. This is a 65.5% increase compared to prevalence of GDM in Homagama MOH area, Colombo in 2004 [14] .
In India prevalence of GDM of 18.9% was reported from an antenatal clinic of a Government Maternity Hospital, Chennai among 891 pregnant women in their second or third trimester (OGTT and WHO 1999 criteria) [23] . A study carried out among 4151, 3960 and 3945 pregnant women in urban, semi urban and rural areas, respectively in South India (Tamil Nadu), reported 17.8% in urban, 13.8% in semi urban and 9.9% in rural areas. Of 1679 women with GDM, 1204 (72%) were detected in the first visit and the remaining in subsequent visits [12] . Several studies have identified increasing maternal BMI as a significant risk factor for GDM [24] [25] [26] . BMI, family history of diabetes mellitus and age ³35 years were found to be independent risk factors for GDM in other studies [27] [28] [29] . Findings from our study were compatible with these findings.
A limitation of the current study is the exclusion of those on prescribed diabetogenic drugs such as steroids, anti-epileptics and anti-psychotics, as well those with severe co morbidities, mental illnesses and pregnant women with miscarriages leading to a somewhat selected sample.
